Furthermore, DDX5 silencing blocked in vivo tumor growth in a murine HCC xenograft model; and high levels of HSP90 and DDX5 were associated with poor prognosis indicating a potential therapeutic biomarker target for HCC [61]. The gene discussed is DDX5; the disease is neoplasm.